Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Nira Varda‐Bloom"'
Autor:
Oren Pleniceanu, Racheli Shukrun, Dorit Omer, Einav Vax, Itamar Kanter, Klaudyna Dziedzic, Naomi Pode‐Shakked, Michal Mark‐Daniei, Sara Pri‐Chen, Yehudit Gnatek, Hadas Alfandary, Nira Varda‐Bloom, Dekel D Bar‐Lev, Naomi Bollag, Rachel Shtainfeld, Leah Armon, Achia Urbach, Tomer Kalisky, Arnon Nagler, Orit Harari‐Steinberg, Jack L Arbiser, Benjamin Dekel
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 4, Pp 508-530 (2017)
Abstract Angiomyolipoma (AML), the most common benign renal tumor, can result in severe morbidity from hemorrhage and renal failure. While mTORC1 activation is involved in its growth, mTORC1 inhibitors fail to eradicate AML, highlighting the need for
Externí odkaz:
https://doaj.org/article/04ce0232c4284454b179f5026fd0dc37
Autor:
Branka Stancevic, Nira Varda-Bloom, Jin Cheng, John D Fuller, Jimmy A Rotolo, Mónica García-Barros, Regina Feldman, Shyam Rao, Ralph R Weichselbaum, Dror Harats, Adriana Haimovitz-Friedman, Zvi Fuks, Michel Sadelain, Richard Kolesnick
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e69025 (2013)
These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acute microvascular endothelial apoptosis initiated via acid sphingomyelinase (ASMase)
Externí odkaz:
https://doaj.org/article/385d5a0a20444620b152eb931564bc92
Publikováno v:
Pediatric Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7344bc07aedac834225cb48b41b4d3f6
https://doi.org/10.1111/petr.14531
https://doi.org/10.1111/petr.14531
Autor:
Elad Jacoby, Omer Bar-Yosef, Noah Gruber, Einat Lahav, Nira Varda-Bloom, Yoav Bolkier, Diana Bar, Moriya Ben-Yakir Blumkin, Sharon Barak, Etzyona Eisenstein, Jaana Ahonniska-Assa, Tamar Silberg, Tal Krasovsky, Orly Bar, Neta Erez, Bella Bielorai, Hana Golan, Benjamin Dekel, Michal J. Besser, Gat Pozner, Hanan Khoury, Alan Jacobs, John Campbell, Eli Herskovitz, Noa Sher, Natalie Yivgi-Ohana, Yair Anikster, Amos Toren
Publikováno v:
Science translational medicine. 14(676)
Patients with single large-scale mitochondrial DNA (mtDNA) deletion syndromes (SLSMDs) usually present with multisystemic disease, either as Pearson syndrome in early childhood or as Kearns-Sayre syndrome later in life. No disease-modifying therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f20c34b004590e839555c095ebbfb2f
https://pubmed.ncbi.nlm.nih.gov/36542693
https://pubmed.ncbi.nlm.nih.gov/36542693
Autor:
Shalev Fried, Roni Shouval, Nira Varda-Bloom, Michal J. Besser, Ronit Yerushalmi, Noga Shem-Tov, Ivetta Danylesko, Elad Jacoby, Shlomit Teihman, Orit Itzhaki, Joshua A. Fein, Meirav Kedmi, Avichai Shimoni, Arnon Nagler, Abraham Avigdor
Publikováno v:
Leukemialymphoma.
Tisagenlecleucel (tisa-cel) is an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved for patients with relapsed/refractory large B-cell lymphoma. Outcomes of patients with out-of-commercial specification (OOS) CAR T products are not we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74756c596bb573d624271f1ad4c702bb
https://pubmed.ncbi.nlm.nih.gov/36111694
https://pubmed.ncbi.nlm.nih.gov/36111694
Autor:
Hila Magen, Avichai Shimoni, Noga Shem-Tov, Arnon Nagler, Nira Varda-Bloom, Ronit Yerushalmi, Rina Sareli, Ivetta Danylesko
Publikováno v:
International Journal of Hematology. 114:363-372
Autologous stem cell transplantation (ASCT) is a standard of care in newly-diagnosed multiple myeloma (MM) patients. Several studies before the introduction of novel therapies in MM, demonstrated a pegylated G-CSF to be successful in mobilizing perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b77ec9c42a2ab69f2893e54a32932b82
https://doi.org/10.1007/s12185-021-03177-9
https://doi.org/10.1007/s12185-021-03177-9
Autor:
Elad Jacoby, Nira Varda-Bloom, Ivetta Danylesko, Arnon Nagler, S. Teihman, Michal J. Besser, Roni Shouval, Abraham Avigdor, Noga Shem-Tov, Ronit Yerushalmi, Avichai Shimoni, Shalev Fried
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bea4fccc68738cd8bc687bbfa691a0d8
https://doi.org/10.1002/hon.182_2880
https://doi.org/10.1002/hon.182_2880
Autor:
Chaim Churi, Nira Varda-Bloom, Daphna Hutt, Helly Vernitsky, Amos Toren, Bella Bielorai, Elad Jacoby
Publikováno v:
Bone Marrow Transplantation. 54:694-697
Haploidntical hematopoietic stem cell transplantation has been increasingly used in recent years for patients without a matched donor. The αβTCR+/CD19+ depletion technique provide a graft that is enriched with CD34 cells, γδ-T-cells and natural k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebee119d7f477122ee72b2a65a89929b
https://doi.org/10.1038/s41409-019-0607-0
https://doi.org/10.1038/s41409-019-0607-0
Autor:
Ivetta, Danylesko, Rina, Sareli, Nira, Varda-Bloom, Ronit, Yerushalmi, Noga, Shem-Tov, Hila, Magen, Avichai, Shimoni, Arnon, Nagler
Publikováno v:
International journal of hematology. 114(3)
Autologous stem cell transplantation (ASCT) is a standard of care in newly-diagnosed multiple myeloma (MM) patients. Several studies before the introduction of novel therapies in MM, demonstrated a pegylated G-CSF to be successful in mobilizing perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5eccbc9794dcb0f5077e205a2680b364
https://pubmed.ncbi.nlm.nih.gov/34213732
https://pubmed.ncbi.nlm.nih.gov/34213732
Autor:
Nira Varda-Bloom, Dorit Omer, Naomi Pode-Shakked, Orit Harari-Steinberg, Leah Armon, Hadas Alfandary, Rachel Shtainfeld, Klaudyna Dziedzic, Oren Pleniceanu, Michal Mark-Daniei, Yehudit Gnatek, Sara Pri-Chen, Arnon Nagler, Tomer Kalisky, Naomi Bollag, Einav Vax, Itamar Kanter, Dekel D. Bar-Lev, Benjamin Dekel, Achia Urbach, Racheli Shukrun, Jack L. Arbiser
Publikováno v:
EMBO Molecular Medicine
Angiomyolipoma (AML), the most common benign renal tumor, can result in severe morbidity from hemorrhage and renal failure. While mTORC1 activation is involved in its growth, mTORC1 inhibitors fail to eradicate AML, highlighting the need for new ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a12dfb79181c69949538946aa27406
https://doi.org/10.15252/emmm.201506111
https://doi.org/10.15252/emmm.201506111